Current management of patients with melanoma who are found to be sentinel node‐positive

BACKGROUND: The results of the DeCOG‐SLT and MSLT‐II studies, published in 2016 and mid‐2017, indicated no survival benefit from completion lymph node dissection (CLND) in melanoma patients with positive sentinel nodes (SNs). Subsequently, several studies have been published reporting a benefit of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nijhuis, Amanda A. G., Spillane, Andrew J., Stretch, Jonathan R., Saw, Robyn P. M., Menzies, Alexander M., Uren, Roger F., Thompson, John F., Nieweg, Omgo E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2019
Materias:
Surgical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216885/
https://www.ncbi.nlm.nih.gov/pubmed/31667924
http://dx.doi.org/10.1111/ans.15491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216885/
https://www.ncbi.nlm.nih.gov/pubmed/31667924
http://dx.doi.org/10.1111/ans.15491

Ejemplares similares